Giorgio Sodero, Pierpaolo Agresti, Silvia Triarico, Alberto Romano, Stefano Mastrangelo, Giorgio Attinà, Palma Maurizi, Clelia Cipolla, Antonio Ruggiero
Brain tumors are the most frequent type of solid neoplasms in children with a recognized 5-year survival rate between 57% and 65%. The survival rate progressively increased in the last few years, due to the improvements in their treatment based on chemotherapy, radiotherapy, and surgery. At the same time, at long term follow-up, clinicians should carefully evaluate comorbidities and long-term sequelae secondary to the disease and its treatment. Growth hormone deficiency (GHD) is an endocrinopathy commonly found among pediatric cancer survivors, with a negative effect on the child's final height and entire metabolism...
June 2022: Minerva pediatrics